nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0622	0.262	CbGbCtD
Bepridil—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0622	0.262	CbGbCtD
Bepridil—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0554	0.234	CbGbCtD
Bepridil—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0293	0.124	CbGbCtD
Bepridil—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0277	0.117	CbGbCtD
Bepridil—TNNC1—connective tissue—chronic obstructive pulmonary disease	0.00655	0.0587	CbGeAlD
Bepridil—CACNA2D2—respiratory system—chronic obstructive pulmonary disease	0.00626	0.0561	CbGeAlD
Bepridil—Trimethaphan—CHRNA3—chronic obstructive pulmonary disease	0.00617	0.812	CrCbGaD
Bepridil—KCNQ1—respiratory system—chronic obstructive pulmonary disease	0.00605	0.0542	CbGeAlD
Bepridil—PDE1A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00524	0.047	CbGeAlD
Bepridil—KCNQ1—bronchus—chronic obstructive pulmonary disease	0.00498	0.0446	CbGeAlD
Bepridil—CACNA1H—smooth muscle tissue—chronic obstructive pulmonary disease	0.00409	0.0367	CbGeAlD
Bepridil—TNNC1—lung—chronic obstructive pulmonary disease	0.00395	0.0354	CbGeAlD
Bepridil—CACNA1C—respiratory system—chronic obstructive pulmonary disease	0.00387	0.0347	CbGeAlD
Bepridil—PDE1A—lung—chronic obstructive pulmonary disease	0.00345	0.031	CbGeAlD
Bepridil—CACNA1C—connective tissue—chronic obstructive pulmonary disease	0.00341	0.0305	CbGeAlD
Bepridil—CACNA2D2—lung—chronic obstructive pulmonary disease	0.00333	0.0298	CbGeAlD
Bepridil—KCNQ1—lung—chronic obstructive pulmonary disease	0.00321	0.0288	CbGeAlD
Bepridil—CACNA1C—smooth muscle tissue—chronic obstructive pulmonary disease	0.00312	0.0279	CbGeAlD
Bepridil—ATP1A1—respiratory system—chronic obstructive pulmonary disease	0.00289	0.0259	CbGeAlD
Bepridil—CALM3—bronchus—chronic obstructive pulmonary disease	0.00267	0.0239	CbGeAlD
Bepridil—CALM3—smooth muscle tissue—chronic obstructive pulmonary disease	0.00261	0.0234	CbGeAlD
Bepridil—CALM2—respiratory system—chronic obstructive pulmonary disease	0.00255	0.0228	CbGeAlD
Bepridil—ATP1A1—connective tissue—chronic obstructive pulmonary disease	0.00254	0.0228	CbGeAlD
Bepridil—CALM1—respiratory system—chronic obstructive pulmonary disease	0.00253	0.0227	CbGeAlD
Bepridil—CALM3—trachea—chronic obstructive pulmonary disease	0.0024	0.0215	CbGeAlD
Bepridil—ATP1A1—bronchus—chronic obstructive pulmonary disease	0.00238	0.0213	CbGeAlD
Bepridil—ATP1A1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00233	0.0209	CbGeAlD
Bepridil—CALM2—connective tissue—chronic obstructive pulmonary disease	0.00224	0.0201	CbGeAlD
Bepridil—CALM1—connective tissue—chronic obstructive pulmonary disease	0.00223	0.02	CbGeAlD
Bepridil—CACNA1D—lung—chronic obstructive pulmonary disease	0.00223	0.02	CbGeAlD
Bepridil—ATP1A1—trachea—chronic obstructive pulmonary disease	0.00214	0.0191	CbGeAlD
Bepridil—CALM2—bronchus—chronic obstructive pulmonary disease	0.00209	0.0188	CbGeAlD
Bepridil—CALM1—bronchus—chronic obstructive pulmonary disease	0.00209	0.0187	CbGeAlD
Bepridil—CACNA1C—lung—chronic obstructive pulmonary disease	0.00205	0.0184	CbGeAlD
Bepridil—CALM2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00205	0.0184	CbGeAlD
Bepridil—CALM1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00204	0.0183	CbGeAlD
Bepridil—CALM2—trachea—chronic obstructive pulmonary disease	0.00188	0.0169	CbGeAlD
Bepridil—CALM1—trachea—chronic obstructive pulmonary disease	0.00187	0.0168	CbGeAlD
Bepridil—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00175	0.00497	CcSEcCtD
Bepridil—Pharyngitis—Tiotropium—chronic obstructive pulmonary disease	0.00174	0.00496	CcSEcCtD
Bepridil—Influenza—Montelukast—chronic obstructive pulmonary disease	0.00174	0.00494	CcSEcCtD
Bepridil—Angina pectoris—Formoterol—chronic obstructive pulmonary disease	0.00173	0.00491	CcSEcCtD
Bepridil—Angina pectoris—Arformoterol—chronic obstructive pulmonary disease	0.00173	0.00491	CcSEcCtD
Bepridil—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00173	0.00491	CcSEcCtD
Bepridil—CALM3—lung—chronic obstructive pulmonary disease	0.00172	0.0154	CbGeAlD
Bepridil—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00171	0.00488	CcSEcCtD
Bepridil—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.0017	0.00483	CcSEcCtD
Bepridil—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.00167	0.00476	CcSEcCtD
Bepridil—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.00167	0.00474	CcSEcCtD
Bepridil—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.00163	0.00464	CcSEcCtD
Bepridil—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00162	0.00462	CcSEcCtD
Bepridil—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00159	0.00453	CcSEcCtD
Bepridil—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00158	0.00448	CcSEcCtD
Bepridil—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.00157	0.00447	CcSEcCtD
Bepridil—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00157	0.00447	CcSEcCtD
Bepridil—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00155	0.0044	CcSEcCtD
Bepridil—ATP1A1—lung—chronic obstructive pulmonary disease	0.00153	0.0138	CbGeAlD
Bepridil—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00152	0.00432	CcSEcCtD
Bepridil—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00149	0.00424	CcSEcCtD
Bepridil—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00144	0.0041	CcSEcCtD
Bepridil—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00143	0.00408	CcSEcCtD
Bepridil—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00407	CcSEcCtD
Bepridil—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00142	0.00405	CcSEcCtD
Bepridil—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.00142	0.00405	CcSEcCtD
Bepridil—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.00142	0.00405	CcSEcCtD
Bepridil—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00141	0.00401	CcSEcCtD
Bepridil—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00141	0.00401	CcSEcCtD
Bepridil—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.00139	0.00396	CcSEcCtD
Bepridil—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00138	0.00392	CcSEcCtD
Bepridil—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00138	0.00392	CcSEcCtD
Bepridil—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00137	0.0039	CcSEcCtD
Bepridil—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00136	0.00386	CcSEcCtD
Bepridil—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00135	0.00385	CcSEcCtD
Bepridil—CALM2—lung—chronic obstructive pulmonary disease	0.00135	0.0121	CbGeAlD
Bepridil—CALM1—lung—chronic obstructive pulmonary disease	0.00135	0.0121	CbGeAlD
Bepridil—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.00383	CcSEcCtD
Bepridil—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.00134	0.00382	CcSEcCtD
Bepridil—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.0038	CcSEcCtD
Bepridil—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.00378	CcSEcCtD
Bepridil—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.00376	CcSEcCtD
Bepridil—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00132	0.00375	CcSEcCtD
Bepridil—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.00375	CcSEcCtD
Bepridil—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00131	0.00374	CcSEcCtD
Bepridil—Shock—Aminophylline—chronic obstructive pulmonary disease	0.0013	0.00371	CcSEcCtD
Bepridil—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.0013	0.00371	CcSEcCtD
Bepridil—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00367	CcSEcCtD
Bepridil—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00127	0.00362	CcSEcCtD
Bepridil—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00127	0.0036	CcSEcCtD
Bepridil—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00127	0.0036	CcSEcCtD
Bepridil—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.00359	CcSEcCtD
Bepridil—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00125	0.00356	CcSEcCtD
Bepridil—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00125	0.00356	CcSEcCtD
Bepridil—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00355	CcSEcCtD
Bepridil—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00125	0.00355	CcSEcCtD
Bepridil—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00124	0.00354	CcSEcCtD
Bepridil—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00354	CcSEcCtD
Bepridil—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.0035	CcSEcCtD
Bepridil—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.00345	CcSEcCtD
Bepridil—Tension—Formoterol—chronic obstructive pulmonary disease	0.00121	0.00345	CcSEcCtD
Bepridil—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00341	CcSEcCtD
Bepridil—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00341	CcSEcCtD
Bepridil—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.0012	0.00341	CcSEcCtD
Bepridil—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.0034	CcSEcCtD
Bepridil—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.00118	0.00336	CcSEcCtD
Bepridil—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.00336	CcSEcCtD
Bepridil—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00117	0.00332	CcSEcCtD
Bepridil—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00329	CcSEcCtD
Bepridil—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00329	CcSEcCtD
Bepridil—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00115	0.00327	CcSEcCtD
Bepridil—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00327	CcSEcCtD
Bepridil—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00325	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00324	CcSEcCtD
Bepridil—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00113	0.00322	CcSEcCtD
Bepridil—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00322	CcSEcCtD
Bepridil—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00113	0.00321	CcSEcCtD
Bepridil—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00112	0.00319	CcSEcCtD
Bepridil—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.00313	CcSEcCtD
Bepridil—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00311	CcSEcCtD
Bepridil—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00109	0.0031	CcSEcCtD
Bepridil—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.0031	CcSEcCtD
Bepridil—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00108	0.00308	CcSEcCtD
Bepridil—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00108	0.00307	CcSEcCtD
Bepridil—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00307	CcSEcCtD
Bepridil—Cough—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00307	CcSEcCtD
Bepridil—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00107	0.00304	CcSEcCtD
Bepridil—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00107	0.00304	CcSEcCtD
Bepridil—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00303	CcSEcCtD
Bepridil—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00303	CcSEcCtD
Bepridil—Cough—Montelukast—chronic obstructive pulmonary disease	0.00106	0.003	CcSEcCtD
Bepridil—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00299	CcSEcCtD
Bepridil—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00299	CcSEcCtD
Bepridil—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00298	CcSEcCtD
Bepridil—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00298	CcSEcCtD
Bepridil—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00298	CcSEcCtD
Bepridil—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00105	0.00298	CcSEcCtD
Bepridil—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00105	0.00298	CcSEcCtD
Bepridil—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00297	CcSEcCtD
Bepridil—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00293	CcSEcCtD
Bepridil—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00293	CcSEcCtD
Bepridil—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00292	CcSEcCtD
Bepridil—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00292	CcSEcCtD
Bepridil—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00292	CcSEcCtD
Bepridil—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00292	CcSEcCtD
Bepridil—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00102	0.0029	CcSEcCtD
Bepridil—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00289	CcSEcCtD
Bepridil—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.00101	0.00907	CbGeAlD
Bepridil—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00287	CcSEcCtD
Bepridil—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00287	CcSEcCtD
Bepridil—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00286	CcSEcCtD
Bepridil—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000993	0.00282	CcSEcCtD
Bepridil—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000989	0.00281	CcSEcCtD
Bepridil—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000987	0.00281	CcSEcCtD
Bepridil—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000987	0.00281	CcSEcCtD
Bepridil—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000971	0.00276	CcSEcCtD
Bepridil—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000952	0.00271	CcSEcCtD
Bepridil—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000936	0.00266	CcSEcCtD
Bepridil—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00092	0.00262	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000918	0.00261	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000918	0.00261	CcSEcCtD
Bepridil—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000912	0.00259	CcSEcCtD
Bepridil—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000912	0.00259	CcSEcCtD
Bepridil—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000907	0.00258	CcSEcCtD
Bepridil—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000906	0.00258	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000899	0.00256	CcSEcCtD
Bepridil—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000899	0.00256	CcSEcCtD
Bepridil—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000899	0.00256	CcSEcCtD
Bepridil—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000896	0.00255	CcSEcCtD
Bepridil—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000896	0.00255	CcSEcCtD
Bepridil—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000893	0.00254	CcSEcCtD
Bepridil—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000887	0.00252	CcSEcCtD
Bepridil—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000887	0.00252	CcSEcCtD
Bepridil—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000886	0.00252	CcSEcCtD
Bepridil—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000878	0.0025	CcSEcCtD
Bepridil—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000876	0.00249	CcSEcCtD
Bepridil—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00087	0.00248	CcSEcCtD
Bepridil—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00087	0.00248	CcSEcCtD
Bepridil—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000869	0.00247	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000867	0.00247	CcSEcCtD
Bepridil—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000862	0.00245	CcSEcCtD
Bepridil—Pain—Formoterol—chronic obstructive pulmonary disease	0.000862	0.00245	CcSEcCtD
Bepridil—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000862	0.00245	CcSEcCtD
Bepridil—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000862	0.00245	CcSEcCtD
Bepridil—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000861	0.00245	CcSEcCtD
Bepridil—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000859	0.00244	CcSEcCtD
Bepridil—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000855	0.00243	CcSEcCtD
Bepridil—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000852	0.00242	CcSEcCtD
Bepridil—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000848	0.00241	CcSEcCtD
Bepridil—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000846	0.00241	CcSEcCtD
Bepridil—Pain—Montelukast—chronic obstructive pulmonary disease	0.000844	0.0024	CcSEcCtD
Bepridil—Phenoxybenzamine—ADRB2—chronic obstructive pulmonary disease	0.000841	0.111	CrCbGaD
Bepridil—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000838	0.00238	CcSEcCtD
Bepridil—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000835	0.00238	CcSEcCtD
Bepridil—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000834	0.00237	CcSEcCtD
Bepridil—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00083	0.00236	CcSEcCtD
Bepridil—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000827	0.00235	CcSEcCtD
Bepridil—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000827	0.00235	CcSEcCtD
Bepridil—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000826	0.00235	CcSEcCtD
Bepridil—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000824	0.00234	CcSEcCtD
Bepridil—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000824	0.00234	CcSEcCtD
Bepridil—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000822	0.00234	CcSEcCtD
Bepridil—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000814	0.00231	CcSEcCtD
Bepridil—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000814	0.00231	CcSEcCtD
Bepridil—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000807	0.0023	CcSEcCtD
Bepridil—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000797	0.00227	CcSEcCtD
Bepridil—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000797	0.00227	CcSEcCtD
Bepridil—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000797	0.00227	CcSEcCtD
Bepridil—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000797	0.00227	CcSEcCtD
Bepridil—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000787	0.00224	CcSEcCtD
Bepridil—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000787	0.00224	CcSEcCtD
Bepridil—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000787	0.00224	CcSEcCtD
Bepridil—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000782	0.00223	CcSEcCtD
Bepridil—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000782	0.00222	CcSEcCtD
Bepridil—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00078	0.00222	CcSEcCtD
Bepridil—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00078	0.00222	CcSEcCtD
Bepridil—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000778	0.00221	CcSEcCtD
Bepridil—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000752	0.00214	CcSEcCtD
Bepridil—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000752	0.00214	CcSEcCtD
Bepridil—ABCB1—trachea—chronic obstructive pulmonary disease	0.000747	0.0067	CbGeAlD
Bepridil—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000742	0.00211	CcSEcCtD
Bepridil—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000723	0.00206	CcSEcCtD
Bepridil—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000723	0.00206	CcSEcCtD
Bepridil—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000708	0.00201	CcSEcCtD
Bepridil—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00069	0.00196	CcSEcCtD
Bepridil—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00069	0.00196	CcSEcCtD
Bepridil—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000686	0.00195	CcSEcCtD
Bepridil—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000683	0.00194	CcSEcCtD
Bepridil—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000675	0.00192	CcSEcCtD
Bepridil—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000666	0.0019	CcSEcCtD
Bepridil—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000666	0.0019	CcSEcCtD
Bepridil—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000653	0.00186	CcSEcCtD
Bepridil—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000651	0.00185	CcSEcCtD
Bepridil—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000642	0.00183	CcSEcCtD
Bepridil—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000635	0.00181	CcSEcCtD
Bepridil—Rash—Formoterol—chronic obstructive pulmonary disease	0.000635	0.00181	CcSEcCtD
Bepridil—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000635	0.00181	CcSEcCtD
Bepridil—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000635	0.00181	CcSEcCtD
Bepridil—Headache—Formoterol—chronic obstructive pulmonary disease	0.000631	0.0018	CcSEcCtD
Bepridil—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000631	0.0018	CcSEcCtD
Bepridil—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00063	0.00179	CcSEcCtD
Bepridil—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000629	0.00179	CcSEcCtD
Bepridil—Rash—Montelukast—chronic obstructive pulmonary disease	0.000622	0.00177	CcSEcCtD
Bepridil—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000622	0.00177	CcSEcCtD
Bepridil—Depression—Prednisone—chronic obstructive pulmonary disease	0.00062	0.00176	CcSEcCtD
Bepridil—Headache—Montelukast—chronic obstructive pulmonary disease	0.000618	0.00176	CcSEcCtD
Bepridil—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000601	0.00171	CcSEcCtD
Bepridil—Rash—Salbutamol—chronic obstructive pulmonary disease	0.0006	0.00171	CcSEcCtD
Bepridil—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.0006	0.00171	CcSEcCtD
Bepridil—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.0006	0.00171	CcSEcCtD
Bepridil—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000599	0.0017	CcSEcCtD
Bepridil—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000599	0.0017	CcSEcCtD
Bepridil—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000596	0.0017	CcSEcCtD
Bepridil—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000588	0.00167	CcSEcCtD
Bepridil—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000586	0.00167	CcSEcCtD
Bepridil—Diphenhydramine—CYP1A2—chronic obstructive pulmonary disease	0.000583	0.0768	CrCbGaD
Bepridil—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000577	0.00164	CcSEcCtD
Bepridil—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000568	0.00162	CcSEcCtD
Bepridil—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000565	0.00161	CcSEcCtD
Bepridil—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000546	0.00155	CcSEcCtD
Bepridil—ABCB1—lung—chronic obstructive pulmonary disease	0.000537	0.00481	CbGeAlD
Bepridil—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000537	0.00153	CcSEcCtD
Bepridil—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000528	0.0015	CcSEcCtD
Bepridil—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000499	0.00142	CcSEcCtD
Bepridil—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000494	0.0014	CcSEcCtD
Bepridil—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00049	0.00139	CcSEcCtD
Bepridil—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000467	0.00133	CcSEcCtD
Bepridil—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000458	0.0013	CcSEcCtD
Bepridil—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000437	0.00124	CcSEcCtD
Bepridil—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000436	0.00124	CcSEcCtD
Bepridil—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000427	0.00122	CcSEcCtD
Bepridil—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.00042	0.00119	CcSEcCtD
Bepridil—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000414	0.00118	CcSEcCtD
Bepridil—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000412	0.00117	CcSEcCtD
Bepridil—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000397	0.00113	CcSEcCtD
Bepridil—Shock—Prednisone—chronic obstructive pulmonary disease	0.00039	0.00111	CcSEcCtD
Bepridil—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000383	0.00109	CcSEcCtD
Bepridil—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000378	0.00108	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000361	0.00103	CcSEcCtD
Bepridil—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000361	0.00103	CcSEcCtD
Bepridil—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000359	0.00102	CcSEcCtD
Bepridil—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000356	0.00101	CcSEcCtD
Bepridil—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000349	0.000993	CcSEcCtD
Bepridil—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000345	0.000981	CcSEcCtD
Bepridil—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000344	0.000979	CcSEcCtD
Bepridil—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000344	0.000978	CcSEcCtD
Bepridil—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000342	0.000973	CcSEcCtD
Bepridil—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000339	0.000965	CcSEcCtD
Bepridil—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000324	0.000923	CcSEcCtD
Bepridil—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000324	0.000922	CcSEcCtD
Bepridil—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000314	0.000892	CcSEcCtD
Bepridil—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000314	0.000892	CcSEcCtD
Bepridil—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000285	0.00081	CcSEcCtD
Bepridil—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000271	0.000772	CcSEcCtD
Bepridil—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000262	0.000746	CcSEcCtD
Bepridil—Rash—Prednisone—chronic obstructive pulmonary disease	0.00025	0.000711	CcSEcCtD
Bepridil—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00025	0.000711	CcSEcCtD
Bepridil—Headache—Prednisone—chronic obstructive pulmonary disease	0.000248	0.000707	CcSEcCtD
Bepridil—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000236	0.00067	CcSEcCtD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.03e-05	0.000138	CbGpPWpGaD
Bepridil—CALM2—Signaling by PDGF—IL6—chronic obstructive pulmonary disease	4.03e-05	0.000138	CbGpPWpGaD
Bepridil—CALM1—Signaling by PDGF—IL6—chronic obstructive pulmonary disease	4.03e-05	0.000138	CbGpPWpGaD
Bepridil—CALM2—Immune System—TLR2—chronic obstructive pulmonary disease	3.96e-05	0.000136	CbGpPWpGaD
Bepridil—CALM1—Immune System—TLR2—chronic obstructive pulmonary disease	3.96e-05	0.000136	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.96e-05	0.000135	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.89e-05	0.000133	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	3.87e-05	0.000132	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—NOS3—chronic obstructive pulmonary disease	3.87e-05	0.000132	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—ALB—chronic obstructive pulmonary disease	3.86e-05	0.000132	CbGpPWpGaD
Bepridil—CALM3—Immune System—KL—chronic obstructive pulmonary disease	3.85e-05	0.000132	CbGpPWpGaD
Bepridil—CALM3—Disease—HDAC2—chronic obstructive pulmonary disease	3.83e-05	0.000131	CbGpPWpGaD
Bepridil—CALM3—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.81e-05	0.00013	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.79e-05	0.00013	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	3.78e-05	0.000129	CbGpPWpGaD
Bepridil—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	3.78e-05	0.000129	CbGpPWpGaD
Bepridil—CALM3—Metabolism—GCLC—chronic obstructive pulmonary disease	3.77e-05	0.000129	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.77e-05	0.000129	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.77e-05	0.000129	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.77e-05	0.000129	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	3.74e-05	0.000128	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	3.74e-05	0.000128	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—ALB—chronic obstructive pulmonary disease	3.73e-05	0.000128	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—ALB—chronic obstructive pulmonary disease	3.73e-05	0.000128	CbGpPWpGaD
Bepridil—CALM2—Immune System—KL—chronic obstructive pulmonary disease	3.73e-05	0.000127	CbGpPWpGaD
Bepridil—CALM1—Immune System—KL—chronic obstructive pulmonary disease	3.73e-05	0.000127	CbGpPWpGaD
Bepridil—CALM2—Disease—HDAC2—chronic obstructive pulmonary disease	3.7e-05	0.000127	CbGpPWpGaD
Bepridil—CALM1—Disease—HDAC2—chronic obstructive pulmonary disease	3.7e-05	0.000127	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—NOS3—chronic obstructive pulmonary disease	3.69e-05	0.000126	CbGpPWpGaD
Bepridil—CALM2—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.69e-05	0.000126	CbGpPWpGaD
Bepridil—CALM1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.69e-05	0.000126	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.67e-05	0.000125	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	3.66e-05	0.000125	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	3.66e-05	0.000125	CbGpPWpGaD
Bepridil—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	3.65e-05	0.000125	CbGpPWpGaD
Bepridil—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	3.65e-05	0.000125	CbGpPWpGaD
Bepridil—CALM2—Metabolism—GCLC—chronic obstructive pulmonary disease	3.65e-05	0.000125	CbGpPWpGaD
Bepridil—CALM1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.65e-05	0.000125	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.62e-05	0.000124	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—NOS3—chronic obstructive pulmonary disease	3.57e-05	0.000122	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—NOS3—chronic obstructive pulmonary disease	3.57e-05	0.000122	CbGpPWpGaD
Bepridil—CALM3—Disease—KL—chronic obstructive pulmonary disease	3.56e-05	0.000122	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—ALB—chronic obstructive pulmonary disease	3.55e-05	0.000121	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.55e-05	0.000121	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.55e-05	0.000121	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.48e-05	0.000119	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.47e-05	0.000119	CbGpPWpGaD
Bepridil—PDE1A—Immune System—EGFR—chronic obstructive pulmonary disease	3.46e-05	0.000118	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.45e-05	0.000118	CbGpPWpGaD
Bepridil—CALM2—Disease—KL—chronic obstructive pulmonary disease	3.44e-05	0.000118	CbGpPWpGaD
Bepridil—CALM1—Disease—KL—chronic obstructive pulmonary disease	3.44e-05	0.000118	CbGpPWpGaD
Bepridil—CALM3—Metabolism—CTGF—chronic obstructive pulmonary disease	3.44e-05	0.000118	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—NOS3—chronic obstructive pulmonary disease	3.4e-05	0.000116	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.36e-05	0.000115	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.36e-05	0.000115	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CTGF—chronic obstructive pulmonary disease	3.33e-05	0.000114	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.33e-05	0.000114	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.32e-05	0.000114	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.31e-05	0.000113	CbGpPWpGaD
Bepridil—PDE1A—Disease—TGFB1—chronic obstructive pulmonary disease	3.26e-05	0.000111	CbGpPWpGaD
Bepridil—PDE1A—Disease—EGFR—chronic obstructive pulmonary disease	3.2e-05	0.000109	CbGpPWpGaD
Bepridil—CALM3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.17e-05	0.000108	CbGpPWpGaD
Bepridil—PDE1B—Immune System—EGFR—chronic obstructive pulmonary disease	3.17e-05	0.000108	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.16e-05	0.000108	CbGpPWpGaD
Bepridil—CALM3—Immune System—CD8A—chronic obstructive pulmonary disease	3.11e-05	0.000106	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.07e-05	0.000105	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.07e-05	0.000105	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.06e-05	0.000105	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.04e-05	0.000104	CbGpPWpGaD
Bepridil—CALM1—Immune System—CD8A—chronic obstructive pulmonary disease	3e-05	0.000103	CbGpPWpGaD
Bepridil—CALM2—Immune System—CD8A—chronic obstructive pulmonary disease	3e-05	0.000103	CbGpPWpGaD
Bepridil—PDE1B—Disease—TGFB1—chronic obstructive pulmonary disease	2.98e-05	0.000102	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.94e-05	0.000101	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.94e-05	0.000101	CbGpPWpGaD
Bepridil—PDE1B—Disease—EGFR—chronic obstructive pulmonary disease	2.92e-05	0.0001	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.91e-05	9.96e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—IL6—chronic obstructive pulmonary disease	2.9e-05	9.93e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.89e-05	9.88e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—ERBB3—chronic obstructive pulmonary disease	2.89e-05	9.88e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.86e-05	9.77e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—IL6—chronic obstructive pulmonary disease	2.81e-05	9.61e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—IL6—chronic obstructive pulmonary disease	2.81e-05	9.61e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.8e-05	9.58e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—ERBB3—chronic obstructive pulmonary disease	2.79e-05	9.56e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—ERBB3—chronic obstructive pulmonary disease	2.79e-05	9.56e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.77e-05	9.47e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.72e-05	9.31e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.69e-05	9.21e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.68e-05	9.16e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—ERBB3—chronic obstructive pulmonary disease	2.67e-05	9.12e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.66e-05	9.11e-05	CbGpPWpGaD
Bepridil—PDE1A—Immune System—IL6—chronic obstructive pulmonary disease	2.66e-05	9.1e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.66e-05	9.1e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.64e-05	9.04e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—CRP—chronic obstructive pulmonary disease	2.64e-05	9.03e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.61e-05	8.91e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.61e-05	8.91e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.59e-05	8.87e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.59e-05	8.87e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—ERBB3—chronic obstructive pulmonary disease	2.58e-05	8.82e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—ERBB3—chronic obstructive pulmonary disease	2.58e-05	8.82e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.57e-05	8.8e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.57e-05	8.8e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.56e-05	8.74e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.56e-05	8.74e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—CRP—chronic obstructive pulmonary disease	2.55e-05	8.74e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—CRP—chronic obstructive pulmonary disease	2.55e-05	8.74e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.53e-05	8.66e-05	CbGpPWpGaD
Bepridil—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.53e-05	8.66e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—TLR4—chronic obstructive pulmonary disease	2.53e-05	8.66e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.52e-05	8.62e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.52e-05	8.62e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.49e-05	8.52e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.49e-05	8.51e-05	CbGpPWpGaD
Bepridil—PDE1A—Disease—IL6—chronic obstructive pulmonary disease	2.46e-05	8.4e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.46e-05	8.4e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—TLR4—chronic obstructive pulmonary disease	2.45e-05	8.38e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—TLR4—chronic obstructive pulmonary disease	2.45e-05	8.38e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.44e-05	8.35e-05	CbGpPWpGaD
Bepridil—PDE1B—Immune System—IL6—chronic obstructive pulmonary disease	2.43e-05	8.32e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.43e-05	8.31e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.41e-05	8.24e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.41e-05	8.24e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.4e-05	8.21e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.36e-05	8.08e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.36e-05	8.08e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.35e-05	8.04e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.35e-05	8.04e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.3e-05	7.87e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.3e-05	7.86e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.28e-05	7.81e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.27e-05	7.78e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.26e-05	7.74e-05	CbGpPWpGaD
Bepridil—PDE1B—Disease—IL6—chronic obstructive pulmonary disease	2.25e-05	7.68e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.24e-05	7.65e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.23e-05	7.62e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.23e-05	7.62e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.22e-05	7.61e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.22e-05	7.61e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—NOS2—chronic obstructive pulmonary disease	2.22e-05	7.6e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—EGFR—chronic obstructive pulmonary disease	2.16e-05	7.37e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—NOS2—chronic obstructive pulmonary disease	2.15e-05	7.36e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—NOS2—chronic obstructive pulmonary disease	2.15e-05	7.36e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.09e-05	7.14e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—EGFR—chronic obstructive pulmonary disease	2.09e-05	7.13e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—EGFR—chronic obstructive pulmonary disease	2.09e-05	7.13e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	2.07e-05	7.08e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.05e-05	7.03e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.05e-05	7e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—TP53—chronic obstructive pulmonary disease	2.01e-05	6.87e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2e-05	6.85e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	2e-05	6.85e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	2e-05	6.85e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.99e-05	6.8e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.99e-05	6.8e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.98e-05	6.76e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—TP53—chronic obstructive pulmonary disease	1.94e-05	6.65e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—TP53—chronic obstructive pulmonary disease	1.94e-05	6.65e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.89e-05	6.46e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.88e-05	6.43e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.88e-05	6.43e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—SERPINE1—chronic obstructive pulmonary disease	1.87e-05	6.4e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.87e-05	6.39e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.86e-05	6.37e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.84e-05	6.3e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.82e-05	6.22e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.82e-05	6.22e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—SERPINE1—chronic obstructive pulmonary disease	1.81e-05	6.19e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—SERPINE1—chronic obstructive pulmonary disease	1.81e-05	6.19e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.81e-05	6.18e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.81e-05	6.18e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.8e-05	6.15e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—NOS3—chronic obstructive pulmonary disease	1.79e-05	6.11e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.75e-05	5.97e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.74e-05	5.95e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.74e-05	5.95e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.73e-05	5.93e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—NOS3—chronic obstructive pulmonary disease	1.73e-05	5.91e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—NOS3—chronic obstructive pulmonary disease	1.73e-05	5.91e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.72e-05	5.88e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.72e-05	5.88e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.67e-05	5.71e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—IL6—chronic obstructive pulmonary disease	1.66e-05	5.66e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL1B—chronic obstructive pulmonary disease	1.65e-05	5.63e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.64e-05	5.62e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.62e-05	5.53e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.62e-05	5.53e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—IL6—chronic obstructive pulmonary disease	1.6e-05	5.48e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—IL6—chronic obstructive pulmonary disease	1.6e-05	5.48e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL1B—chronic obstructive pulmonary disease	1.59e-05	5.45e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL1B—chronic obstructive pulmonary disease	1.59e-05	5.45e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.57e-05	5.38e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—ALB—chronic obstructive pulmonary disease	1.57e-05	5.35e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—ALB—chronic obstructive pulmonary disease	1.51e-05	5.18e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—ALB—chronic obstructive pulmonary disease	1.51e-05	5.18e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.5e-05	5.12e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.45e-05	4.95e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.45e-05	4.95e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.37e-05	4.7e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.33e-05	4.55e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.33e-05	4.55e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.31e-05	4.48e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.27e-05	4.34e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.27e-05	4.34e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—EGFR—chronic obstructive pulmonary disease	1.26e-05	4.29e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.25e-05	4.28e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—EGFR—chronic obstructive pulmonary disease	1.21e-05	4.15e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—EGFR—chronic obstructive pulmonary disease	1.21e-05	4.15e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.21e-05	4.14e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.21e-05	4.14e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.19e-05	4.06e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—TGFB1—chronic obstructive pulmonary disease	1.18e-05	4.04e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—EGFR—chronic obstructive pulmonary disease	1.16e-05	3.96e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—TGFB1—chronic obstructive pulmonary disease	1.14e-05	3.91e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—TGFB1—chronic obstructive pulmonary disease	1.14e-05	3.91e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.13e-05	3.88e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—EGFR—chronic obstructive pulmonary disease	1.12e-05	3.83e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—EGFR—chronic obstructive pulmonary disease	1.12e-05	3.83e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	1.12e-05	3.82e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.11e-05	3.8e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.07e-05	3.67e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.07e-05	3.67e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.07e-05	3.66e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.06e-05	3.61e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.02e-05	3.49e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.02e-05	3.49e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1e-05	3.43e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.72e-06	3.32e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.72e-06	3.32e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL6—chronic obstructive pulmonary disease	9.65e-06	3.3e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL6—chronic obstructive pulmonary disease	9.33e-06	3.19e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL6—chronic obstructive pulmonary disease	9.33e-06	3.19e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.02e-06	3.08e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—IL6—chronic obstructive pulmonary disease	8.91e-06	3.05e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.72e-06	2.98e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.72e-06	2.98e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—IL6—chronic obstructive pulmonary disease	8.62e-06	2.95e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—IL6—chronic obstructive pulmonary disease	8.62e-06	2.95e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.28e-06	2.83e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.12e-06	2.78e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.01e-06	2.74e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.01e-06	2.74e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.85e-06	2.69e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.85e-06	2.69e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.81e-06	2.33e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.59e-06	2.25e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.59e-06	2.25e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.24e-06	2.13e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.03e-06	2.06e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.03e-06	2.06e-05	CbGpPWpGaD
